ArticleJournal of clinical pharmacology2026

Disproportionality Analysis of Intravitreal Ranibizumab, Aflibercept, and Brolucizumab for Cardiovascular and Cerebrovascular Events.

Keisuke Nosaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.